ryanodine and Leukemia--Myeloid

ryanodine has been researched along with Leukemia--Myeloid* in 1 studies

Other Studies

1 other study(ies) available for ryanodine and Leukemia--Myeloid

ArticleYear
The inositol 1,4,5-trisphosphate-generating agonist ATP enhances DNA cleavage induced by tert-butylhydroperoxide.
    Experimental cell research, 1998, Feb-25, Volume: 239, Issue:1

    In this paper we present experimental evidence indicating that DNA cleavage induced by tert-butylhydroperoxide in U937 cells can be enhanced via ATP-mediated activation of membrane receptors coupled with hydrolysis of phosphatidylinositol 4,5-bisphosphate. The mechanism whereby ATP exerts this effect involves release of Ca2+ from the inositol 1,4,5-trisphosphate (IP3)-sensitive stores, further release of the cation from the ryanodine receptor, mitochondrial clearance of the fraction of Ca2+ derived from the ryanodine receptor, and Ca2(+)-dependent mitochondrial formation of DNA-damaging species. IP3-generating agonists must therefore be considered as potential modulators of the genotoxic effects of tert-butylhydroperoxide.

    Topics: Adenosine Triphosphate; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; DNA Damage; DNA, Neoplasm; Humans; Inositol 1,4,5-Trisphosphate; Kinetics; Leukemia, Myeloid; Mitochondria; Peroxides; Reactive Oxygen Species; Ryanodine; Ryanodine Receptor Calcium Release Channel; tert-Butylhydroperoxide; Tumor Cells, Cultured

1998